Careers

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2023 National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2023 National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

HSCA Urges DEA to Take Steps to Mitigate Shortages of Injectable Opioids

March 9, 2018 by admin 2018 Press Releases 0 comments
Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph., today released the following statement encouraging the Drug Enforcement Administration (DEA) to take critical steps to ease current shortages of injectable opioids:
“Hospitals and other healthcare providers are currently experiencing critical shortages of a number of injectable opioid medications – including morphine, hydromorphone, and fentanyl – that are an essential element of treatment for post – surgical and medical pain management. Without the necessary opioids available, many medical procedures would have to be postponed or cancelled, jeopardizing the wellbeing of patients across the country. Controlling narcotics use – particularly outpatient prescription opioid abuse – remains a public health priority that HSCA supports.”
Read the full press release…
Next

Related Posts

HSCA Urges DEA to Take Steps to Mitigate Shortages of Injectable Opioids
March 9, 2018

Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph.,...

Learn more
HSCA Announces Healthcare Cybersecurity Key Considerations
April 17, 2018

The Healthcare Supply Chain Association (HSCA) today announced the release of key...

Learn more
HSCA Comments on DEA Proposed Rule on Opioid Production Limits
May 4, 2018

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more
HSCA Comments on FDA Bulk Substance Guidance
May 25, 2018

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Response to Congressional RFI on the Pandemic and All-Hazards Preparedness Act (PAHPA)
    March 16, 2023
  • HSCA STATEMENT ON STATE OF THE UNION ADDRESS
    February 8, 2023